TONIX PHARMACEUTICALS HOLDING CORP. (NASDAQ:TNXP) Files An 8-K Other Events

TONIX PHARMACEUTICALS HOLDING CORP. (NASDAQ:TNXP) Files An 8-K Other Events
Item 8.01

On December 3, 2019, Tonix Pharmaceuticals Holding Corp. (the “Company”) issued a press release announcing that on December 2, 2019, the Company received a letter from The NASDAQ Stock Market LLC (“NASDAQ”) stating that because the Company’s shares had a closing bid price at or above $1.00 per share for a minimum of ten consecutive business days, the Company’s stock had regained compliance with the minimum bid price requirement of $1.00 per share for continued listing on the NASDAQ Global Market, as set forth in NASDAQ Listing Rule 5450(a)(1), and that the matter is now closed. A copy of the press release that discusses this matter is filed as Exhibit 99.01 to, and incorporated by reference in, this report.

99.01 Press Release dated December 3, 2019, issued by the Company


Tonix Pharmaceuticals Holding Corp. Exhibit
EX-99.01 2 ex99-01.htm PRESS RELEASE   TONIX PHARMACEUTICALS HOLDING CORP. 8-K   Exhibit 99.01   Tonix Pharmaceuticals Regains Compliance with NASDAQ Minimum Bid Price Requirement   NEW YORK,…
To view the full exhibit click here

An ad to help with our costs